Search Results

You are looking at 51 - 60 of 292 items for :

  • "Neoadjuvant chemotherapy" x
  • Refine by Access: All x
Clear All
Full access

CLO23-040: Electrocardiographic Findings in Cancer Patients Receiving Chemotherapy From the Colombian Coffee Triangle Region

Andres Garcia, David Medina, Alejandra Palacio, Andrés Vallejo, Luz Adriana Díaz, Juan Darío Franco, Tatiana Taborda, and María José Rojas

Background: Some antineoplastic agents are known for their cardiotoxicity, especially anthracyclines, used for breast cancer neoadjuvant chemotherapy and induction treatment for some hematological malignancies. Nevertheless, there is scarce

Full access

Trends in Neoadjuvant Approaches in Pancreatic Cancer

Lingling Du and Andrea Wang-Gillam

a better insight into the role and best strategy of neoadjuvant chemoRT. Neoadjuvant Chemotherapy PDAC has a high propensity for early development of metastasis. The role of RT in PDAC remains controversial even in the adjuvant setting and

Full access

Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Frank Balis, Daniel M. Green, Clarke Anderson, Shelly Cook, Jasreman Dhillon, Kenneth Gow, Susan Hiniker, Rama Jasty-Rao, Chi Lin, Harold Lovvorn III, Iain MacEwan, Julian Martinez-Agosto, Elizabeth Mullen, Erin S. Murphy, Mark Ranalli, Daniel Rhee, Denise Rokitka, Elisabeth (Lisa) Tracy, Tamara Vern-Gross, Michael F. Walsh, Amy Walz, Jonathan Wickiser, Matthew Zapala, Ryan A. Berardi, and Miranda Hughes

neoadjuvant chemotherapy is determined at week 6, especially if a biopsy was not performed at initial presentation. Information that can be obtained through biopsy is limited. A diagnosis of FHWT obtained on a biopsy implies that focal or diffuse anaplasia

Full access

Induction Chemotherapy for Head and Neck Cancer: Will History Repeat Itself?

Athanassios Argiris

Surg 1987 ; 10 : 19 – 30 . 3 Taylor SGT . Why has so much chemotherapy done so little in head and neck cancer? J Clin Oncol 1987 ; 5 : 1 – 3 . 4 Rosenthal DI Pistenmaa DA Glatstein E . A review of neoadjuvant chemotherapy

Full access

Adjuvant Therapy for Soft Tissue Sarcoma

Scott M. Schuetze and Michael E. Ray

. Ifosfamide in the adjuvant therapy of soft tissue sarcomas . Oncology 2003 ; 65 ( suppl 2 ): 80 – 84 . 30 DeLaney TF Spiro IJ Suit HD . Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas . Int J Radiat Oncol

Full access

NCCN Guidelines Update: Evolving Radiation Therapy Recommendations for Breast Cancer

Kilian E. Salerno

invasive carcinoma. These recommendations are not applicable for APBI or patients who have received neoadjuvant chemotherapy. Hypofractionation: Preferred for Whole-Breast RT For most women receiving whole-breast irradiation, hypofractionation is

Full access

Importance of Node Dissection in Relation to Neoadjuvant and Adjuvant Therapy

William C. Huang and Bernard H. Bochner

, multinational, multicenter, phase III study . J Clin Oncol 2000 ; 18 : 3068 – 3077 . 19. Grossman HB Natale RB Tangen CM . Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer . N Engl J Med

Full access

Locoregional Management of Early-Stage Breast Cancer

Presented by: Benjamin O. Anderson and Janice A. Lyons

neoadjuvant treatment,” he said. The 4-arm SENTINA trial concluded that SLNB is reliable before neoadjuvant chemotherapy is given. 12 But after neoadjuvant chemotherapy and with conversion from clinically positive to clinically negative, SLNB has a high false

Full access

CLO22-059: Chemotherapy Timing and Outcomes in Early Breast Cancer

Kristen Kelley, Audrey York, Benjamin Haaland, Xuechen Wang, Shiven Patel, Adriana Coletta, and Christos Vaklavas

chemotherapy may be superior. The objective of this study is to assess the relationship between dose timing and outcomes in breast cancer patients. Methods : 153 patients who had neoadjuvant chemotherapy in 2014-2020 were included. Chemotherapy administration

Full access

CLO20-050: Effect of Tumor Grade on Neoadjuvant Treatment Outcome in Esophageal Cancer

Jordan McDonald, Rutika Mehta, Sarah Hoffe, and Jose Pimiento

stage 1 disease were much less likely to receive neoadjuvant chemotherapy than those with stage 3 disease. Tumor grade was not significantly associated with treatment response (P=0.551), negative margin resection (P=0.252), disease recurrence (P=0